Abstract
Purpose of Review
Aortic regurgitation (AR) is a common form of valvular disease which is characterized by reflux of blood from the aorta into the left ventricle (LV) during diastole. AR results from various etiologies, affecting the aortic valve cusps or the aortic root. The clinical presentation of patients with AR depends on the severity of the regurgitation and differs whether AR develops acutely or if it progresses over a prolonged period, allowing the cardiac chambers to adapt. Echocardiography is the primary method to determine the etiology of AR and to define its severity. We review the current data regarding the diagnosis and treatment of AR.
Recent Findings
No single parameter is sufficient to determine AR severity; thus, an integrative, multi-parametric approach is required. Echocardiography is key for imaging the aortic valve morphology and flow as well as aortic root and ascending aorta. Determining LV ejection fraction and dimensions is essential for patient management and optimizing timing for intervention. Three-dimensional (3D) echocardiography is useful in the evaluation of AR etiology and severity. The use of Trasncatheter aortic valve replacement (TAVR) has emerged as an alternative to surgery in patients at high operative risk.
Summary
The diagnosis and management of AR requires a comprehensive approach and routine clinical and echocardiographic follow-up. Surgical or percutaneous therapy is indicated when symptoms develop and in those who have LV dysfunction or LV dilation.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Supino PG, Borer JS, Preibisz J, Bornstein A. The epidemiology of valvular heart disease: a growing public health problem. Heart Fail Clin. 2006;2(4):379–93. https://doi.org/10.1016/j.hfc.2006.09.010.
Siu SC, Silversides CK. Bicuspid aortic valve disease. J Am Coll Cardiol. 2010;55(25):2789–800. https://doi.org/10.1016/j.jacc.2009.12.068.
Ross J Jr. Afterload mismatch in aortic and mitral valve disease: implications for surgical therapy. J Am Coll Cardiol. 1985;5(4):811–26.
Goldbarg SH, Halperin JL. Aortic regurgitation: disease progression and management. Nat Clin Pract Cardiovasc Med. 2008;5(5):269–79. https://doi.org/10.1038/ncpcardio1179.
Sutton M, Plappert T, Spiegel A, Raichlen J, Douglas P, Reichek N, et al. Early postoperative changes in left ventricular chamber size, architecture, and function in aortic stenosis and aortic regurgitation and their relation to intraoperative changes in afterload: a prospective two-dimensional echocardiographic study. Circulation. 1987;76(1):77–89.
Carabello BA. Aortic regurgitation. A lesion with similarities to both aortic stenosis and mitral regurgitation. Circulation. 1990;82(3):1051–3.
Wisenbaugh T, Spann JF, Carabello BA. Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation. J Am Coll Cardiol. 1984;3(4):916–23.
Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975;56(1):56–64. https://doi.org/10.1172/JCI108079.
Rigolin VH, Bonow RO. Hemodynamic characteristics and progression to heart failure in regurgitant lesions. Heart Fail Clin. 2006;2(4):453–60. https://doi.org/10.1016/j.hfc.2006.09.009.
Nitenberg A, Foult JM, Antony I, Blanchet F, Rahali M. Coronary flow and resistance reserve in patients with chronic aortic regurgitation, angina pectoris and normal coronary arteries. J Am Coll Cardiol. 1988;11(3):478–86.
Tamborini G, Barbier P, Doria E, Bortone F, Sisillo E, Susini G, et al. Coronary flow and left ventricular diastolic function in aortic regurgitation. Coron Artery Dis. 1995;6(8):635–43.
Mann DL, Zipes DP, Libby P, Bonow RO, Braunwald E. Braunwald’s heart disease : a textbook of cardiovascular medicine. Tenth ed. Philadelphia: Elsevier/Saunders; 2015.
Fortuin NJ, Craige E. On the mechanism of the Austin Flint murmur. Circulation. 1972;45(3):558–70.
Bekeredjian R, Grayburn PA. Valvular heart disease: aortic regurgitation. Circulation. 2005;112(1):125–34. https://doi.org/10.1161/CIRCULATIONAHA.104.488825.
Thomson HL, Basmadjian AJ, Rainbird AJ, Razavi M, Avierinos JF, Pellikka PA, et al. Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective, randomly assigned, blinded study. J Am Coll Cardiol. 2001;38(3):867–75.
La Canna G, Maisano F, De Michele L, Grimaldi A, Grassi F, Capritti E, et al. Determinants of the degree of functional aortic regurgitation in patients with anatomically normal aortic valve and ascending thoracic aorta aneurysm. Transoesophageal Doppler echocardiography study. Heart. 2009;95(2):130–6. https://doi.org/10.1136/hrt.2007.134494.
Perry GJ, Helmcke F, Nanda NC, Byard C, Soto B. Evaluation of aortic insufficiency by Doppler color flow mapping. J Am Coll Cardiol. 1987;9(4):952–9.
•• Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303–71. https://doi.org/10.1016/j.echo.2017.01.007 This report is a state-of-the-art comprehensive review on the echocardiographic assessment of valvular regurgitation.
Tribouilloy CM, Enriquez-Sarano M, Bailey KR, Seward JB, Tajik AJ. Assessment of severity of aortic regurgitation using the width of the vena contracta: a clinical color Doppler imaging study. Circulation. 2000;102(5):558–64.
Perez de Isla L, Zamorano J, Fernandez-Golfin C, Ciocarelli S, Corros C, Sanchez T, et al. 3D color-Doppler echocardiography and chronic aortic regurgitation: a novel approach for severity assessment. Int J Cardiol. 2013;166(3):640–5. https://doi.org/10.1016/j.ijcard.2011.11.094.
Skaug TR, Amundsen BH, Hergum T, Urheim S, Torp H, Haugen BO. Quantification of aortic regurgitation using high-pulse repetition frequency three-dimensional colour Doppler. Eur Heart J Cardiovasc Imaging. 2014;15(6):615–22. https://doi.org/10.1093/ehjci/jet255.
Enriquez-Sarano M, Miller FA Jr, Hayes SN, Bailey KR, Tajik AJ, Seward JB. Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method. J Am Coll Cardiol. 1995;25(3):703–9. https://doi.org/10.1016/0735-1097(94)00434-R.
Tribouilloy CM, Enriquez-Sarano M, Fett SL, Bailey KR, Seward JB, Tajik AJ. Application of the proximal flow convergence method to calculate the effective regurgitant orifice area in aortic regurgitation. J Am Coll Cardiol. 1998;32(4):1032–9.
Labovitz AJ, Ferrara RP, Kern MJ, Bryg RJ, Mrosek DG, Williams GA. Quantitative evaluation of aortic insufficiency by continuous wave Doppler echocardiography. J Am Coll Cardiol. 1986;8(6):1341–7.
Teague SM, Heinsimer JA, Anderson JL, Sublett K, Olson EG, Voyles WF, et al. Quantification of aortic regurgitation utilizing continuous wave Doppler ultrasound. J Am Coll Cardiol. 1986;8(3):592–9.
Tribouilloy C, Avinee P, Shen WF, Rey JL, Slama M, Lesbre JP. End diastolic flow velocity just beneath the aortic isthmus assessed by pulsed Doppler echocardiography: a new predictor of the aortic regurgitant fraction. Br Heart J. 1991;65(1):37–40.
Reimold SC, Maier SE, Aggarwal K, Fleischmann KE, Piwnica-Worms D, Kikinis R, et al. Aortic flow velocity patterns in chronic aortic regurgitation: implications for Doppler echocardiography. J Am Soc Echocardiogr. 1996;9(5):675–83.
Enriquez-Sarano M, Bailey KR, Seward JB, Tajik AJ, Krohn MJ, Mays JM. Quantitative Doppler assessment of valvular regurgitation. Circulation. 1993;87(3):841–8.
Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Doppler Quantification Task Force of the N et al. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr. 2002;15(2):167–84.
Buser PT, Auffermann W, Holt WW, Wagner S, Kircher B, Wolfe C, et al. Noninvasive evaluation of global left ventricular function with use of cine nuclear magnetic resonance. J Am Coll Cardiol. 1989;13(6):1294–300.
Cranney GB, Lotan CS, Dean L, Baxley W, Bouchard A, Pohost GM. Left ventricular volume measurement using cardiac axis nuclear magnetic resonance imaging. Validation by calibrated ventricular angiography. Circulation. 1990;82(1):154–63.
Cawley PJ, Hamilton-Craig C, Owens DS, Krieger EV, Strugnell WE, Mitsumori L, et al. Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography. Circ Cardiovasc Imaging. 2013;6(1):48–57. https://doi.org/10.1161/CIRCIMAGING.112.975623.
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):e521–643. https://doi.org/10.1161/CIR.0000000000000031.
•• Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–91. https://doi.org/10.1093/eurheartj/ehx391 The European Society of Cardiology (ESC) 2017 guidelines are currently the most recent guidelines for the management of valve diseases.
Levine HJ, Gaasch WH. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. J Am Coll Cardiol. 1996;28(5):1083–91. https://doi.org/10.1016/S0735-1097(96)00288-4.
Shen WF, Roubin GS, Hirasawa K, Uren RF, Hutton BF, Harris PJ, et al. Noninvasive assessment of acute effects of nifedipine on rest and exercise hemodynamics and cardiac function in patients with aortic regurgitation. J Am Coll Cardiol. 1984;4(5):902–7.
Elder DH, Wei L, Szwejkowski BR, Libianto R, Nadir A, Pauriah M, et al. The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study. J Am Coll Cardiol. 2011;58(20):2084–91. https://doi.org/10.1016/j.jacc.2011.07.043.
Sampat U, Varadarajan P, Turk R, Kamath A, Khandhar S, Pai RG. Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients. J Am Coll Cardiol. 2009;54(5):452–7. https://doi.org/10.1016/j.jacc.2009.02.077.
Allen BD, Markl M, Barker AJ, van Ooij P, Carr JC, Malaisrie SC, et al. Influence of beta-blocker therapy on aortic blood flow in patients with bicuspid aortic valve. Int J Card Imaging. 2016;32(4):621–8. https://doi.org/10.1007/s10554-015-0819-3.
Cohn LH, Birjiniuk V. Therapy of acute aortic regurgitation. Cardiol Clin. 1991;9(2):339–52.
Ergin MA, McCullough J, Galla JD, Lansman SL, Griepp RB. Radical replacement of the aortic root in acute type A dissection: indications and outcome. Eur J Cardiothorac Surg. 1996;10(10):840–4 discussion 5.
Pompilio G, Brockmann C, Bruneau M, Buche M, Amrani M, Louagie Y, et al. Long-term survival after aortic valve replacement for native active infective endocarditis. Cardiovasc Surg. 1998;6(2):126–32.
Edwards FH, Peterson ED, Coombs LP, DeLong ER, Jamieson WR, Shroyer ALW, et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol. 2001;37(3):885–92.
Aronow WS, Ahn C, Kronzon I, Nanna M. Prognosis of patients with heart failure and unoperated severe aortic valvular regurgitation and relation to ejection fraction. Am J Cardiol. 1994;74(3):286–8.
Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB. Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms. J Am Coll Cardiol. 1997;30(3):746–52.
Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation. 1999;99(14):1851–7.
Kari FA, Siepe M, Sievers HH, Beyersdorf F. Repair of the regurgitant bicuspid or tricuspid aortic valve: background, principles, and outcomes. Circulation. 2013;128(8):854–63. https://doi.org/10.1161/CIRCULATIONAHA.113.002475.
Brown JM, O’Brien SM, Wu C, Sikora JAH, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg. 2009;137(1):82–90. https://doi.org/10.1016/j.jtcvs.2008.08.015.
Martin E, Dagenais F, Voisine P, Dumont E, Charbonneau E, Baillot R, et al. Surgical aortic valve replacement outcomes in the transcatheter era. J Thorac Cardiovasc Surg. 2015;150(6):1582–8. https://doi.org/10.1016/j.jtcvs.2015.08.077.
Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231–43.
Franzone A, Piccolo R, Siontis GC, Lanz J, Stortecky S, Praz F, et al. Transcatheter aortic valve replacement for the treatment of pure native aortic valve regurgitation: A Systematic Review. JACC Cardiovasc Interv. 2016;9(22):2308–17. https://doi.org/10.1016/j.jcin.2016.08.049.
• Yoon SH, Schmidt T, Bleiziffer S, Schofer N, Fiorina C, Munoz-Garcia AJ, et al. Transcatheter aortic valve replacement in pure native aortic valve regurgitation. J Am Coll Cardiol. 2017;70(22):2752–63. https://doi.org/10.1016/j.jacc.2017.10.006 This study is currently the largest registry of TAVR in pure aortic regurgitation, providing important outcome data.
Urena M, Himbert D, Ohlmann P, Capretti G, Goublaire C, Kindo M, et al. Transcatheter aortic valve replacement to treat pure aortic regurgitation on noncalcified native valves. J Am Coll Cardiol. 2016;68(15):1705–6. https://doi.org/10.1016/j.jacc.2016.07.746.
Wernly B, Eder S, Navarese EP, Kretzschmar D, Franz M, Alushi B, et al. Transcatheter aortic valve replacement for pure aortic valve regurgitation: “on-label” versus “off-label” use of TAVR devices. Clin Res Cardiol. 2019. https://doi.org/10.1007/s00392-019-01422-0.
Beigel R, Siegel RJ. Aortic regurgitation: pathophysiology. In: Lang R, Goldstein SA, Kronzon I, Khandheria BK, Mor-Avi V, editors. ASE’s comprehensive echocardiography. second ed. Philadelphia: Elsevier Saunders; 2016. p. 442–6.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Nir Flint, Nina C. Wunderlich, Hezzy Shmueli, Sagit Ben-Zekry, Robert J. Siegel, and Roy Beigel declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Structural Heart Disease
Electronic Supplementary Material
Transesophageal echo long-axis view with and without color Doppler showing thickened aortic cusps and malcoaptation secondary to a flail right aortic cusp. There is severe aortic regurgitation with an eccentric regurgitant jet directed towards the anterior mitral leaflet. (AVI 6084 kb)
Transesophageal echo long-axis view showing malcoaptation of the aortic valve cusps secondary to severe dilation of the aortic root and ascending aorta. (AVI 14969 kb)
Color Doppler from the same patient as in video 2 showing severe aortic regurgitation (AR). Note the large flow convergence and vena contracta as well as the regurgitant jet which fills most of the left ventricular outflow tract, all consistent with severe AR. (AVI 8915 kb)
Rights and permissions
About this article
Cite this article
Flint, N., Wunderlich, N.C., Shmueli, H. et al. Aortic Regurgitation. Curr Cardiol Rep 21, 65 (2019). https://doi.org/10.1007/s11886-019-1144-6
Published:
DOI: https://doi.org/10.1007/s11886-019-1144-6